Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis
- PMID: 6556002
- DOI: 10.1111/j.1699-0463.1983.tb00047.x
Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis
Abstract
Population analyses of susceptibility to methicillin, vancomycin, cephalothin, cefamandole, and cefoxitin were carried out with two strains of Staphylococcus epidermidis (S. epidermidis) resistant to penicillin, streptomycin, and methicillin. Two strains of Staphylococcus aureus (S. aureus), one sensitive to penicillin the other resistant, were used as controls. All strains were clinical isolates. From the strains of S. epidermidis it was possible to select sub-populations highly resistant to methicillin, cephalothin, cefamandole, and cefoxitin. The mutation-rate varied between c. 10(-3) and 10(-7). The two strains were homogeneous as regards vancomycin susceptibility. Methicillin was shown to be more penicillinase-stable than the cephalosporines. Treatment in vivo, with cephalothin and vancomycin did not increase the frequency of highly resistant bacteria against any of the antibiotics, but during treatment with cephalothin the majority-population became eight times more resistant to vancomycin and may explain why the treatment in vivo was not successful.
Similar articles
-
Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.Antimicrob Agents Chemother. 1979 Nov;16(5):655-9. doi: 10.1128/AAC.16.5.655. Antimicrob Agents Chemother. 1979. PMID: 260880 Free PMC article.
-
Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime.Acta Pathol Microbiol Immunol Scand B. 1983 Dec;91(6):425-9. doi: 10.1111/j.1699-0463.1983.tb00071.x. Acta Pathol Microbiol Immunol Scand B. 1983. PMID: 6324530
-
Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.J Infect Dis. 1979 Apr;139(4):452-7. doi: 10.1093/infdis/139.4.452. J Infect Dis. 1979. PMID: 438546
-
Recognition and importance of Staphylococcus epidermidis infections.Clin Pharm. 1987 Jun;6(6):464-75. Clin Pharm. 1987. PMID: 3319361 Review.
-
Methicillin-resistant staphylococci: detection methods and treatment of infections.Antimicrob Agents Chemother. 1989 Jul;33(7):995-9. doi: 10.1128/AAC.33.7.995. Antimicrob Agents Chemother. 1989. PMID: 2675760 Free PMC article. Review. No abstract available.
Cited by
-
Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.Clin Microbiol Rev. 1988 Jul;1(3):281-99. doi: 10.1128/CMR.1.3.281. Clin Microbiol Rev. 1988. PMID: 3058297 Free PMC article. Review.
-
Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.Antimicrob Agents Chemother. 1986 May;29(5):748-52. doi: 10.1128/AAC.29.5.748. Antimicrob Agents Chemother. 1986. PMID: 3460523 Free PMC article.
-
Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.Antimicrob Agents Chemother. 1988 Jan;32(1):63-7. doi: 10.1128/AAC.32.1.63. Antimicrob Agents Chemother. 1988. PMID: 2831815 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources